COVID-19 in rheumatic disease patients on immunosuppressive agents

OBJECTIVE: To analyze clinical characteristics and outcome of COVID-19 patients with underlying rheumatic diseases (RD) on immunosuppressive agents. METHOD: A case series of COVID-19 patients with RD on disease modifying anti-rheumatic drugs (DMARDs) were studied by a retrospective chart review. A l...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharmeen, Saika, Elghawy, Ahmed, Zarlasht, Fnu, Yao, Qingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245236/
https://www.ncbi.nlm.nih.gov/pubmed/32512263
http://dx.doi.org/10.1016/j.semarthrit.2020.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245236/
https://www.ncbi.nlm.nih.gov/pubmed/32512263
http://dx.doi.org/10.1016/j.semarthrit.2020.05.010

Ejemplares similares